---
title: "aisidi has established a new e-commerce company in Wuhan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230813033.md"
description: "According to the Qichacha APP, recently, Wuhan aisidi E-commerce Co., Ltd. was established, with Wu Lei as the legal representative and a registered capital of 1 million yuan. The business scope includes: sales of electronic products; information technology consulting services; marketing planning; graphic design, etc. Qichacha's equity penetration shows that the company is wholly owned by aisidi"
datetime: "2025-03-06T10:57:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230813033.md)
  - [en](https://longbridge.com/en/news/230813033.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230813033.md)
generator: "portal-rs"
---

# aisidi has established a new e-commerce company in Wuhan

According to the Qichacha APP, recently, Wuhan aisidi E-commerce Co., Ltd. was established, with Wu Lei as the legal representative and a registered capital of 1 million yuan. The business scope includes: sales of electronic products; information technology consulting services; marketing planning; graphic design, etc. Qichacha's equity penetration shows that the company is wholly owned by aisidi

### Related Stocks

- [002416.CN](https://longbridge.com/en/quote/002416.CN.md)

## Related News & Research

- [Ecommerce Trends: What's different about Amazon's approach to AI commerce](https://longbridge.com/en/news/297220919.md)
- [WeChat team open-sources WeMM-Embedding for multimodal search and recommendation](https://longbridge.com/en/news/297135591.md)
- [Canada minister says he welcomes US clarification on French language requirements](https://longbridge.com/en/news/297196718.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [Abundia Global Impact Group launches USD 5 million share buyback program](https://longbridge.com/en/news/297051929.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**